Management Team

Dr. Ryals received a Ph.D. in Molecular Biology from the University of Texas at Dallas. Prior to joining Metabolon, Dr. Ryals was CEO, president and founder of Paradigm Genetics, Inc. (NASDAQ:PDGM). There, he raised over $100 million in equity financing, including an Initial Public Offering in 2000 and a follow on offering in 2001 and closed on R&D partnerships valued at over $200 million. Dr. Ryals has 20 years of experience in the biotechnology industry including senior research positions at Novartis and Ciba-Geigy and currently serves on the Board of North Carolina State University College of Physical and Mathematical Sciences.

Mr. Lynch is a certified public accountant with 20 years of executive and financial experience with life science companies and public accounting. Prior to joining Metabolon, Mr. Lynch was vice president, global finance for the clinical division of Inveresk, a contract research organization and subsidiary of Charles River Laboratories. Mr. Lynch also served in various financial roles for GlaxoSmithKline and gained seven years of public accounting experience with Coopers & Lybrand specializing in healthcare and manufacturing.

Dr. Milburn received his Ph.D. in structural chemistry at the University of California, Berkeley and was a research fellow at Harvard Medical School for his post-doctoral work. Before joining Metabolon, Dr. Milburn was senior vice president of research and corporate development at Sirtris Pharmaceuticals where he led the preclinical/clinical development of projects in the areas of metabolic disease and neurodegeneration. Prior to Sirtris, Dr. Milburn was senior vice president of research at Plexxikon, Inc., responsible for the development of Plexxikon's proprietary high-throughput cocrystallography drug discovery platform. Dr. Milburn has over 15 years of experience in biotech and pharmaceutical companies including previous positions at Structural Genomix and GlaxoSmithKline.

Mr. Zack has +30 years of broad business experience in the biopharmaceutical and diagnostic industry, with the last +10 years at the Executive Management level, building organizations and launching new products. He recently joined Metabolon as Senior Vice President, Diagnostics. Since 2002, Mr. Zack was Executive Vice President, Marketing and Sales for Orasure Technologies ( Bethlehem, PA), where he grew and expanded the diagnostic/device business substantially behind the very successful launch of the first rapid HIV test, as well as portfolio and international expansion. From 1998 to 2002, Mr. Zack was Vice President, Sales and Marketing for OraPharma ( Westminster, PA), where he built and led all commercial operations from start-up through IPO, successfully launching a novel locally delivered antibiotic for periodontal disease. Prior to that, he was with Advanced Tissue Sciences (San Diego, CA) from 1993-1998, and as General Manager, led the global commercialization of the first tissue engineered products in wound care. Mr. Zack started his career in 1973 with Ciba-Geigy Pharmaceuticals, where he spent 20 years with increasing responsibility in Sales, New Product Development, and Marketing, with the last seven years as Executive Director of Marketing, substantially growing the business through numerous successful product launches, mainly in the cardiovascular space. Mr. Zack has a B.A. from Colgate University and an MBA from St. John’s University.

Mr. Bernard joined Metabolon in August 2009 to direct the expansion and management of its service business. He is a flexible, innovative leader with 15+ years of sales and marketing experience and a proven track record of building high performing teams able to deliver business critical results under aggressive timelines. Mr. Bernard came to Metabolon from Abaxis Inc, where as Vice President of Sales and Marketing he built the sales, marketing, technical and customer service groups for the medical diagnostic business. Prior to that, from 1995 to 2005, Mr. Bernard held various sales and sales management positions at Cytyc Corp, now Hologic. He finished his career at Cytyc as a Regional Business Director. Mr. Bernard holds a bachelor’s degree in psychobiology from Hiram College, is a board certified Cytologist; and is currently on the board of directors for the Hiram College Integrated Entrepreneurship Program.